Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Skyepharma CFO gets cash injection from Vectura merger

Mon, 20th Jun 2016 13:41

(ShareCast News) - Skyepharma's chief financial officer Andrew Derodra has pocketed a healthy cash injection after the completion of the merger with Vectura.Derodra exercised nil-cost options over 150,000 Skyepharma shares that were a bonus in his long-term incentive plan that vested on completion of the merger on Friday and so were automatically converted into new Vectura shares.Under the merger agreement, shares in Skyepharma are exchanged for ordinary shares of 0.025 pence in Vectura at a ratio of 2.7977405 Vectura shares for each Skyepharma share.Derodra, who is remaining part of the management team of the enlarged group, later on Friday sold all 419,661 of his new Vectura shares in London at an average price of £1.536209 per share, making over £644,000.The combined group will see Derodra led by James Ward-Lilley, Vectura's chief executive officer, in the CEO seat, with Vectura's Trevor Phillips as chief operating officer and Vectura chairman Bruno Angelici also chairman of the enlarged group. Top Director BuysGlobalworth Real Estate Investments Limited (GWI)Director name: Papalekas,Ioannis Amount purchased: 10,000 @ € 5.15Value: € 51,500.00Hikma Pharmaceuticals (HIK)Director name: Darwazah,MazenAmount purchased: 70,000 @ 21.65pValue: £15,155.00Hikma Pharmaceuticals (HIK)Director name: Darwazah,SaidAmount purchased: 70,000 @ 21.65pValue: £15,155.00Hikma Pharmaceuticals (HIK)Director name: Al-Husry,AliAmount purchased: 70,000 @ 21.65pValue: £15,155.00Stilo International (STL)Director name: Ashman,DavidAmount purchased: 200,000 @ 5.63pValue: £11,250.00U And I Group (UAI)Director name: Weiner,MatthewAmount purchased: 20,985 @ 1.85pValue: £388.22Johnson Matthey (JMAT)Director name: MacLeod,RobertAmount purchased: 12 @ 2,889.00pValue: £346.68Johnson Matthey (JMAT)Director name: Walker,JohnAmount purchased: 12 @ 2,889.00pValue: £346.68Top Director SellsVectura Group (VEC)Director name: Derodra,AndrewOption sale: 419,661 @ 153.62pValue: £644,687.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Whitehead,PeterAmount purchased: 20,391 @ 1,201.00pValue: £244,895.91Young & Co's Brewery 'a' Shares (YNGA)Director name: Goodyear,StephenAmount purchased: 15,000 @ 1,201.00pValue: £180,150.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Sligo-Young,TorquilAmount purchased: 8,000 @ 1,201.00pValue: £96,080.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Sligo-Young,TorquilAmount purchased: 2,500 @ 1,201.00pValue: £30,025.00
More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.